Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Positive association between CD44 gene rs13347 C>T polymorphism and risk of cancer in Asians: a systemic review and meta-analysis.

Shi J, Duan Y, Pan L, Zhou X.

Onco Targets Ther. 2016 Jun 13;9:3493-500. doi: 10.2147/OTT.S104734.

2.

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.

Thapa R, Wilson GD.

Stem Cells Int. 2016;2016:2087204. doi: 10.1155/2016/2087204. Review.

3.

Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation.

Li JH, Wang YC, Qin CD, Yao RR, Zhang R, Wang Y, Xie XY, Zhang L, Wang YH, Ren ZG.

Am J Cancer Res. 2016 Jan 15;6(2):509-21.

5.

Hyaluronan: More than just a wrinkle filler.

Maytin EV.

Glycobiology. 2016 Jun;26(6):553-9. doi: 10.1093/glycob/cww033. Review.

PMID:
26964566
6.

Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells.

Sim MW, Grogan PT, Subramanian C, Bradford CR, Carey TE, Forrest ML, Prince ME, Cohen MS.

Laryngoscope. 2016 May;126(5):E184-90. doi: 10.1002/lary.25808.

PMID:
26690734
7.

Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.

Leinung M, Ernst B, Döring C, Wagenblast J, Tahtali A, Diensthuber M, Stöver T, Geissler C.

Oncol Lett. 2015 Oct;10(4):2289-2294.

8.

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.

Chen Y, Song J, Jiang Y, Yu C, Ma Z.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):11287-95.

9.

Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.

Zhu LC, Gao J, Hu ZH, Schwab CL, Zhuang HY, Tan MZ, Yan LM, Liu JJ, Zhang DY, Lin B.

Am J Cancer Res. 2015 Jan 15;5(2):830-43.

10.

Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.

Chan KC, Chan LS, Ip JC, Lo C, Yip TT, Ngan RK, Wong RN, Lo KW, Ng WT, Lee AW, Tsao GS, Kahn M, Lung ML, Mak NK.

Sci Rep. 2015 Apr 21;5:9979. doi: 10.1038/srep09979.

11.

Modulation of CD44 Activity by A6-Peptide.

Finlayson M.

Front Immunol. 2015 Mar 30;6:135. doi: 10.3389/fimmu.2015.00135. Review.

12.

The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine.

Karbownik MS, Pietras T, Szemraj J, Kowalczyk E, Nowak JZ.

Contemp Oncol (Pozn). 2014;18(5):323-8. doi: 10.5114/wo.2014.43493.

13.

Hyaluronan-phosphatidylethanolamine polymers form pericellular coats on keratinocytes and promote basal keratinocyte proliferation.

Symonette CJ, Kaur Mann A, Tan XC, Tolg C, Ma J, Perera F, Yazdani A, Turley EA.

Biomed Res Int. 2014;2014:727459. doi: 10.1155/2014/727459.

14.

CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.

Chou YE, Hsieh MJ, Chiou HL, Lee HL, Yang SF, Chen TY.

Biomed Res Int. 2014;2014:231474. doi: 10.1155/2014/231474.

15.

Expression and clinical significance of colorectal cancer stem cell marker EpCAMhigh/CD44+ in colorectal cancer.

Liu D, Sun J, Zhu J, Zhou H, Zhang X, Zhang Y.

Oncol Lett. 2014 May;7(5):1544-1548.

16.

CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.

Chou YE, Hsieh MJ, Hsin CH, Chiang WL, Lai YC, Lee YH, Huang SC, Yang SF, Lin CW.

PLoS One. 2014 Apr 3;9(4):e93692. doi: 10.1371/journal.pone.0093692.

17.

Hepatocyte nuclear factor (HNF)-1β and its physiological importance in endometriosis.

Akasaka J, Uekuri C, Shigetomi H, Koike M, Kobayashi H.

Biomed Rep. 2013 Jan;1(1):13-17. Review.

18.
19.

The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma.

Shah A, Patel S, Pathak J, Swain N, Kumar S.

ScientificWorldJournal. 2014 Jan 21;2014:842491. doi: 10.1155/2014/842491. Review.

20.

Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma.

Feng C, Zhang Y, Yin J, Li J, Abounader R, Zuo Z.

Neuro Oncol. 2014 Aug;16(8):1078-85. doi: 10.1093/neuonc/nou010.

Items per page

Supplemental Content

Support Center